141 related items for PubMed ID: 16408431
1. [Clinical outcome assessment of membranous nephropathy].
Kumagai T, Shimizu H, Nishi T, Mise N, Tagawa H, Sugimoto T.
Nihon Jinzo Gakkai Shi; 2005; 47(8):870-5. PubMed ID: 16408431
[Abstract] [Full Text] [Related]
2. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[Abstract] [Full Text] [Related]
3. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ, Wetzels JF.
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[Abstract] [Full Text] [Related]
4. Cyclosporin A treatment for idiopathic membranous nephropathy.
Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L.
Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
[Abstract] [Full Text] [Related]
5. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[Abstract] [Full Text] [Related]
6. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
Hofstra JM, Deegens JK, Willems HL, Wetzels JF.
Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
[Abstract] [Full Text] [Related]
7. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
Hofstra JM, Branten AJ, Wirtz JJ, Noordzij TC, du Buf-Vereijken PW, Wetzels JF.
Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912
[Abstract] [Full Text] [Related]
8. Long-term outcome of patients with idiopathic membranous nephropathy.
Ríhová Z, Merta M, Maixnerová D, Honsová E, Reiterová J, Rysavá R, Zabka J, Tesar V.
Prague Med Rep; 2006 Jan; 107(2):189-98. PubMed ID: 17066739
[Abstract] [Full Text] [Related]
9. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW, Wetzels JF.
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[Abstract] [Full Text] [Related]
10. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
Eriguchi M, Oka H, Mizobuchi T, Kamimura T, Sugawara K, Harada A.
Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558
[Abstract] [Full Text] [Related]
11. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V.
J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
[Abstract] [Full Text] [Related]
12. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.
Torres A, Domínguez-Gil B, Carreño A, Hernández E, Morales E, Segura J, González E, Praga M.
Kidney Int; 2002 Jan; 61(1):219-27. PubMed ID: 11786104
[Abstract] [Full Text] [Related]
13. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.
Naumovic R, Furuncic D, Jovanovic D, Stosovic M, Basta-Jovanovic G, Lezaic V.
Biomed Pharmacother; 2010 Nov; 64(9):633-8. PubMed ID: 20888177
[Abstract] [Full Text] [Related]
14. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
Naumovic R, Jovanovic D, Pavlovic S, Stosovic M, Marinkovic J, Basta-Jovanovic G.
Biomed Pharmacother; 2011 Mar; 65(2):105-10. PubMed ID: 21109389
[Abstract] [Full Text] [Related]
15. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[Abstract] [Full Text] [Related]
16. Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy.
Kibriya MG, Tishkov I, Nikolov D.
Nephrol Dial Transplant; 1994 Nov; 9(2):138-43. PubMed ID: 8190328
[Abstract] [Full Text] [Related]
17. Effective treatment administration of cyclophosphamide in membranous nephropathy.
Dede F, Ayili D, Sahiner S.
J Nephrol; 2008 Nov; 21(4):560-5. PubMed ID: 18651546
[Abstract] [Full Text] [Related]
18. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
Polanco N, Gutiérrez E, Rivera F, Castellanos I, Baltar J, Lorenzo D, Praga M, Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN).
Nephrol Dial Transplant; 2012 Jan; 27(1):231-4. PubMed ID: 21624942
[Abstract] [Full Text] [Related]
19. [Prognosis and treatment of membranous glomerulonephritis-a 5-year prospective study].
Covic A, Căruntu ID, Marian D, Volovăţ C, Ghiciuc C, Costin C, Florea L, Cotuţiu C, Covic M.
Rev Med Chir Soc Med Nat Iasi; 2000 Jan; 104(2):63-74. PubMed ID: 12089993
[Abstract] [Full Text] [Related]
20. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
Am J Nephrol; 2007 Jan; 27(3):226-31. PubMed ID: 17389782
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
